Skip to content

The Role of TCM on ERAS of Rectal Cancer Patients

The Role of Traditional Chinese Medicine on Enhanced Recovery After Surgery for Patients With Rectal Cancer Undergoing Curative Surgery: A Randomized Controlled Trial

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04749381
Acronym
RCT
Enrollment
264
Registered
2021-02-11
Start date
2020-09-28
Completion date
2023-02-20
Last updated
2021-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Keywords

ERAS, Integrative medicine, Acupoint application, Compliance, Quality of life

Brief summary

This study is to investigate the role of traditional Chinese medicine (TCM) on the postoperative recovery of rectal cancer patients.

Detailed description

The hypothesis is that TCM can decrease the postoperative complications for rectal cancer. So the study is to investigate the role of traditional Chinese medicine (TCM) on the postoperative recovery of rectal cancer patients. Patients enrolled in this study will be randomized into two groups with TCM intervention or placebo. The intervention will be described below. Primary endpoint is postoperative complications.

Interventions

COMBINATION_PRODUCTacupoint with TCM

The acupoint application was made of traditional Chinese medicine (TCM), and the therapeutic effect was produced through the stimulation of TCM drugs and acupoints.

COMBINATION_PRODUCTacupoint with placebo

The placebo acupoint application was made of black beans and honey, which shares the similar shape and smell of the experiment group, applied at the same acupoints.

Sponsors

Peking University Cancer Hospital & Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Patients enrolled are randomized into acupoint application group and placebo acupoint application group

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Signed written consent form; * Age from 18 to 75 years old; * Pathological diagnosis as rectal adenocarcinoma; * undergo laparoscopic curative surgery; * Patients' TCM syndrome accords with thoses of spleen deficiency syndrome;

Exclusion criteria

* Patients undergo non-curative surgeries; * Participants with skin allergy, skin ulceration and diabetes mellitus with poor glycemic control; * Participants with severe dysfunction of heart, liver and kidney, who could not receive TCM treatment; * Women who are pregnant or breastfeeding; * Participants have mental illness or have difficulty in language communication and are unable to complete the study; * Participants could not cooperate with this researcher for other reasons.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative complicationsfrom operation to 30 days after operationRates of the complications after curative surgery

Secondary

MeasureTime frameDescription
recovery of urinary functionfrom removal of urinary catheter to 30 days after operationThe rates of urinary retention after removal of urinary catheter
Recovery of fart and bowel function7 days after operationThe time of the first tart and first defecation after operation in days
The European Organization of Quality of Life Questionnaire-colorectal-2930 days after operationCancer Quality of Life Questionnaire-Colorectal-29, with scale from 1 to 4 for each items as QOL becomes poorer.
Changes of TCM symptoms30 days after operationChanges of traditional Chinese medicine symptoms: all symptoms were recorded by 10 simple questions and then will be categorized in 4 different groups. The aim of study tries to show the relationship with TCM application with the symptoms.
Length of hospital stay30 days after operationTime of hospital stay in days

Countries

China

Contacts

Primary ContactNan Chen, M.D.;Ph.D
chennanpku@126.com+86 18911956939

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026